Awakn Life Sciences Discusses Filing of Financial Statements @awakn_ls #Biotechnology #Investing #OTCmarkets #OTCstocks #Technology #Chemicals #CSEStocks #OTC #SmallCaps
Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or the "Company"), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on Alcohol Use Disorder (AUD), announces that, it intends to file its audited annual financial statements and MD&A for the financial year ended January 31, 2024 (the "Financial Statements") by May 30, 2024, in line with the standard...
http://dlvr.it/T6LXSc
http://dlvr.it/T6LXSc
Comments
Post a Comment